4//SEC Filing
Henderson Molly 4
Accession 0000950170-25-052156
CIK 0001783183other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:01 PM ET
Size
5.8 KB
Accession
0000950170-25-052156
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2025-04-07$4.55/sh−3,678$16,740→ 89,868 total
Holdings
- 1,911.27(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices $4.55 to $4.57. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001363812
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:01 PM ET
- Size
- 5.8 KB